Back to resultsUsing a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
Primary Purpose
Sarcoma, Lung, Solid Tumor Gastrointestinal
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
SMS/MMS text messaging
usual care
Sponsored by
About this trial
This is an interventional other trial for Sarcoma focused on measuring texting, Adherence to Oral Anticancer Medications, 16-810
Eligibility Criteria
Inclusion Criteria:
- Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
- Starting a new treatment regimen that includes a single oral anticancer medication
- Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
- Age 18 or older.
- Ability to speak and read English because we do not have the resources to translate the text messages into other languages.
Exclusion Criteria:
- Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.
Sites / Locations
- Memorial Sloan Kettering Cancer Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
SMS/MMS text messaging
usual care
Arm Description
Patients will be able to tailor their SMS/MMS reminders with respect to when (i.e., what time of day) they wish to receive the reminders, as well as how often the messages are sent (e.g., morning and evening).
This includes physician and nursing assessment and intervention for any identified AEs. Of note, there is not currently standard follow-up that patients receive from nursing or physician staff while on an OAM treatment. Patients are encouraged to call their physician's office with any questions or changes in their medical status but are not called routinely by MSK staff.
Outcomes
Primary Outcome Measures
objective pill count
is greater or less than the amount of OAM that the patient should have in their possession.
Secondary Outcome Measures
Full Information
NCT ID
NCT02833246
First Posted
July 12, 2016
Last Updated
November 16, 2018
Sponsor
Memorial Sloan Kettering Cancer Center
1. Study Identification
Unique Protocol Identification Number
NCT02833246
Brief Title
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
Official Title
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
Study Type
Interventional
2. Study Status
Record Verification Date
November 2018
Overall Recruitment Status
Completed
Study Start Date
June 28, 2016 (Actual)
Primary Completion Date
November 14, 2018 (Actual)
Study Completion Date
November 14, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Memorial Sloan Kettering Cancer Center
4. Oversight
5. Study Description
Brief Summary
This study is being done to determine if sending reminder text messages helps patients take their Oral Anticancer Medication (OAMs) when they are supposed to.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcoma, Lung, Solid Tumor Gastrointestinal
Keywords
texting, Adherence to Oral Anticancer Medications, 16-810
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
28 (Actual)
8. Arms, Groups, and Interventions
Arm Title
SMS/MMS text messaging
Arm Type
Experimental
Arm Description
Patients will be able to tailor their SMS/MMS reminders with respect to when (i.e., what time of day) they wish to receive the reminders, as well as how often the messages are sent (e.g., morning and evening).
Arm Title
usual care
Arm Type
Active Comparator
Arm Description
This includes physician and nursing assessment and intervention for any identified AEs. Of note, there is not currently standard follow-up that patients receive from nursing or physician staff while on an OAM treatment. Patients are encouraged to call their physician's office with any questions or changes in their medical status but are not called routinely by MSK staff.
Intervention Type
Other
Intervention Name(s)
SMS/MMS text messaging
Intervention Description
text messaging reminders on oral chemotherapy medication adherence
Intervention Type
Other
Intervention Name(s)
usual care
Primary Outcome Measure Information:
Title
objective pill count
Description
is greater or less than the amount of OAM that the patient should have in their possession.
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient in the Sarcoma, Solid Tumor Gastrointestinal (ST GI), and Thoracic Medicine service at MSK.
Starting a new treatment regimen that includes a single oral anticancer medication
Patients must have a mobile phone that can send and receive SMS/MMS messages and is internet-enabled.
Age 18 or older.
Ability to speak and read English because we do not have the resources to translate the text messages into other languages.
Exclusion Criteria:
Patient expresses inability or unfamiliarity with using SMS/MMS messaging on their phone and is unwilling to be trained in the use of this technology.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Thomas Atkinson, PhD
Organizational Affiliation
Memorial Sloan Kettering Cancer Center
Official's Role
Principal Investigator
Facility Information:
Facility Name
Memorial Sloan Kettering Cancer Center
City
New York
State/Province
New York
ZIP/Postal Code
10065
Country
United States
12. IPD Sharing Statement
Links:
URL
https://www.mskcc.org/
Description
Memorial Sloan Kettering Cancer Center
Learn more about this trial
Using a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer Medications
We'll reach out to this number within 24 hrs